Cargando…

Clinical Significance of Cartilage Biomarkers for Monitoring Structural Joint Damage in Rheumatoid Arthritis Patients Treated with Anti-TNF Therapy

PURPOSE: With the current use of biologics in rheumatoid arthritis (RA), there is a need to monitor ongoing structural joint damage due to the dissociation of articular cartilage damage from disease activity of RA. This study longitudinally analyzed levels of serum cartilage biomarkers during 54 wee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niki, Yasuo, Takeuchi, Tsutomu, Nakayama, Masanori, Nagasawa, Hayato, Kurasawa, Takahiko, Yamada, Harumoto, Toyama, Yoshiaki, Miyamoto, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357428/ https://www.ncbi.nlm.nih.gov/pubmed/22629396 http://dx.doi.org/10.1371/journal.pone.0037447

Ejemplares similares

IL-32-PAR2 axis is an innate immunity sensor providing alternative signaling for LPS-TRIF axis
por: Nakayama, Masanori, et al.
Publicado: (2013)

Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients—REACTION 52-week study
por: Takeuchi, Tsutomu, et al.
Publicado: (2011)

Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study)
por: Takeuchi, Tsutomu, et al.
Publicado: (2011)

Enhanced susceptibility to lipopolysaccharide-induced arthritis and endotoxin shock in interleukin-32 alpha transgenic mice through induction of tumor necrosis factor alpha
por: Nakayama, Masanori, et al.
Publicado: (2012)

Significant association between joint ultrasonographic parameters and synovial inflammatory factors in rheumatoid arthritis
por: Kondo, Yasushi, et al.
Publicado: (2019)

Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis
por: Okuyama, Ayumi, et al.
Publicado: (2010)

Evaluating joint-space narrowing and cartilage loss in rheumatoid arthritis by using MRI
por: Peterfy, Charles G, et al.
Publicado: (2012)

Finger Joint Cartilage Evaluated by Semiquantitative Ultrasound Score in Patients With Rheumatoid Arthritis
por: Ogura, Takehisa, et al.
Publicado: (2021)

Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study
por: Takeuchi, Tsutomu, et al.
Publicado: (2014)

Identification of neutrophil β2-integrin LFA-1 as a potential mechanistic biomarker in ANCA-associated vasculitis via microarray and validation analyses
por: Matsumoto, Kotaro, et al.
Publicado: (2021)

Stat3 as a potential therapeutic target for rheumatoid arthritis
por: Oike, Takatsugu, et al.
Publicado: (2017)

Structural cartilage damage attracts circulating rheumatoid arthritis synovial fibroblasts into affected joints
por: Hillen, Jan, et al.
Publicado: (2017)

Rheumatoid arthritis sera antibodies to citrullinated collagen type II bind to joint cartilage
por: Li, Qixing, et al.
Publicado: (2022)

Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists
por: Finckh, Axel, et al.
Publicado: (2012)

Cartilage and bone damage in rheumatoid arthritis
por: Ostrowska, Monika, et al.
Publicado: (2018)

Overview of biotherapy in rheumatoid arthritis (RA)
por: Takeuchi, Tsutomu, et al.
Publicado: (2012)

Reprogrammed siTNFα/neutrophil cytopharmaceuticals targeting inflamed joints for rheumatoid arthritis therapy
por: Chen, Yijun, et al.
Publicado: (2023)

Treadmill Running in Established Phase Arthritis Inhibits Joint Destruction in Rat Rheumatoid Arthritis Models
por: Fujii, Yuta, et al.
Publicado: (2019)

Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction
por: Tanaka, Yoshiya, et al.
Publicado: (2020)

What is the future of CCR5 antagonists in rheumatoid arthritis?
por: Takeuchi, Tsutomu, et al.
Publicado: (2012)

Association of Pulse Pressure with Serum TNF-α and Neutrophil Count in the Elderly
por: Yamada, Eriko, et al.
Publicado: (2014)

Bone and TNF in rheumatoid arthritis: clinical implications
por: Manara, Maria, et al.
Publicado: (2015)

Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα NANOBODY(®) compound, in patients with rheumatoid arthritis: 52-week results from the OHZORA and NATSUZORA trials
por: Takeuchi, Tsutomu, et al.
Publicado: (2023)

Analysis of Mitogen-Activated Protein Kinases in Bone and Cartilage of Patients with Rheumatoid Arthritis Treated with Abatacept
por: Kanbe, Katsuaki, et al.
Publicado: (2016)

TNF-α and TNF-β Gene Polymorphism in Saudi Rheumatoid Arthritis Patients
por: Al-Rayes, Hannan, et al.
Publicado: (2011)

The Effect of TNF and Non-TNF-Targeted Biologics on Body Composition in Rheumatoid Arthritis
por: Vial, Gaelle, et al.
Publicado: (2021)

Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 Study
por: Tahir, Hasan, et al.
Publicado: (2017)

Molecular remission at T cell level in patients with rheumatoid arthritis
por: Inamo, Jun, et al.
Publicado: (2021)

Comminuted distal humeral fracture treated using the Ilizarov technique in a patient with rheumatoid arthritis and osteoporosis
por: Chida, Shuichi, et al.
Publicado: (2016)

High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study
por: Takeuchi, Tsutomu, et al.
Publicado: (2017)

Maackia amurensis seed lectin (MASL) ameliorates articular cartilage destruction and increases movement velocity of mice with TNFα induced rheumatoid arthritis
por: Hamilton, Kelly L., et al.
Publicado: (2022)

Proof-of-Concept Double-Blind Placebo-Controlled Trial Measuring Cartilage Composition in Early Rheumatoid Arthritis under TNF-α-Inhibitor Therapy
por: Frenken, Miriam, et al.
Publicado: (2023)

The Floating Cartilage in Joints
por: Martin, W. J.
Publicado: (1897)

Treatment of rheumatoid arthritis with biological agents — as a typical and common immune-mediated inflammatory disease
por: TAKEUCHI, Tsutomu
Publicado: (2017)

Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis
por: Yokoyama-Kokuryo, Waka, et al.
Publicado: (2020)

New approaches to inhibiting TNF production in rheumatoid arthritis: is pathological TNF regulated in the same way as protective TNF?
por: Feldmann, M, et al.
Publicado: (2001)

Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis
por: Said, Cynthia, et al.
Publicado: (2013)

The Treatment of Joints in Rheumatoid Arthritis
por: Lindsay, James
Publicado: (1907)

Addendum to “Treatment of rheumatoid arthritis with biological agents — as a typical and common immune-mediated inflammatory disease”
por: TAKEUCHI, Tsutomu
Publicado: (2018)

Increased migratory activity and cartilage regeneration by superficial-zone chondrocytes in enzymatically treated cartilage explants
por: Shiromoto, Yuichiro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p2k5s1pjgh9ibsg0o9k2ikubrf